JRCT ID: jRCTs042200006
Registered date:27/04/2020
Study on utility of a cognitive function test program
Basic Information
Recruitment status | Complete |
---|---|
Health condition(s) or Problem(s) studied | Alzheimer's disease, mild cognitive impairment |
Date of first enrollment | 28/08/2020 |
Target sample size | 60 |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | effort and time for manupilation of a tablet |
Outcome(s)
Primary Outcome | - Accuracy and response time at each task of A-003 |
---|---|
Secondary Outcome | - Total time for completion of A-003 - Comparison and correlation of each task of A-003 with neurophycological tests - Discrimination ability of A-003 among groups (sensitivity/specificity, AUC of ROC curve) |
Key inclusion & exclusion criteria
Age minimum | >= 55age old |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | 1. Subjects who sign an informed consent 2. subjects who can manipulate a tablet 3. outpatient and medication are not asked. 4. A statistically significant difference is not observed in terms of things like an age between groups. (1) Alzheimers disease - Subjects who are diagnosed with diagnostic guidelines for Alzheimers disease from the National Institute on Aging-Alzheimers Association workgroups where assessment for decline of cognitive function is carried out with the ADNI criteria. - Subjects who are certainly diagnosed after first visit. (2) mild cognitive impairment - Subjects who are diagnosed with diagnostic guidelines mild cognitive impairment due to Alzheimers disease from the National Institute on Aging-Alzheimers Association workgroups where assessment for decline of cognitive function is carried out with the ADNI criteria. - Subjects who are certainly diagnosed after first visit. (3) healthy volunteer - Subjects who are finally diagnosed to be healthy after assessment. - Subjects who accompany outpatients. |
Exclude criteria | - Subjects with psychiatric disorders like major depression disorder, bipolar disorder, epilepsy or schizophrenia - Subjects who may have epilepsy or photosensitivity by light stimulation - Subjects who are judged to be unacceptable by medical doctors |
Related Information
Primary Sponsor | Takechi Hajime |
---|---|
Secondary Sponsor | Life Science Institute Inc. |
Source(s) of Monetary Support | |
Secondary ID(s) |
Contact
Public contact | |
Name | Hajime Takechi |
Address | 1-98 Dengakugakubo, Kutsutake-cho, Toyoake, Aichi 470-1192, Japan Aichi Japan 470-1192 |
Telephone | +81-562-93-9083 |
takechi@fujita-hu.ac.jp | |
Affiliation | Fujita Health University Hospital |
Scientific contact | |
Name | Hajime Takechi |
Address | 1-98 Dengakugakubo, Kutsutake-cho, Toyoake, Aichi 470-1192, Japan Aichi Japan 470-1192 |
Telephone | +81-562-93-9083 |
takechi@fujita-hu.ac.jp | |
Affiliation | Fujita Health University Hospital |